UltraGreen.ai’s post-IPO performance is an important gauge of investor interest
It represents the kind of high-tech players that investors have been clamouring to see listed on the local bourse
Add BT as a preferred source
[SINGAPORE] After years of lamenting the lack of high-tech, growth-focused companies on the Singapore Exchange (SGX), investors are getting their wish granted with the upcoming debut of UltraGreen.ai.
The company develops fluorescence-guided surgery technology, offers fluorescence imaging services and supplies indocyanine green dyes used in surgical procedures. More importantly, it represents the kind of high-tech players that investors have been clamouring to see listed on the local bourse.
UltraGreen.ai is laying the foundation for success with a high-powered board. Kwa Chong Seng, former SGX and ST Engineering chairman, is the non-independent non-executive chairman. Hsieh Fu Hua, former SGX CEO and once a director at Grab, is the lead independent director.
TRENDING NOW
Firm loses wrongful dismissal case despite following termination clause
Vietnam seeks US$76 billion a year from capital markets to ease reliance on banks
Soilbuild’s Lim Chap Huat sues Brookfield, claims it reneged on joint venture: WSJ
Citi, OCBC downgrade UOB post-Q2 results; RHB upgrades on valuation
